Cardiolite Injection, Powder, Lyophilized, For Solution
Product Images NDC 11994-001

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cardiolite (NDC 11994-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lantheus Medical Imaging, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1.0 (Cardiolite 01)

An instructional diagram showing a rectangular chromatography plate labeled with dimensions and key features such as the solvent front at the top, a cut line at 7.5 cm from the bottom, and the origin marked by a small shape near the bottom. Measurements indicate 1 cm from top to solvent front baseline, 2.5 cm solvent front area, 2.5 cm cut region, and 1.5 cm from bottom to origin.*

FDA Label Image

Principal Display Panel (5 Vial Box)

Packaging label for Cardiolite injection, powder, lyophilized for solution, 1 mg/mL, labeled by Lantheus Medical Imaging, Inc. The label identifies it as a kit for the preparation of Technetium Tc99m Sestamibi for injection. It includes storage conditions, component descriptions, and licensing information in text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.